Newsletter update from the Faustman Lab:
"Dear Friends,
We've come a long way since 2001, when we first announced we could reverse type 1 diabetes-in mice. Today, all of our type 1 diabetes work is in humans. In fact, we no longer even have mice at the lab! Our success, which includes bringing a generic drug called BCG successfully through Phase I testing, is the fruition of over 20 years of research-research that has helped to redefine how we look at the treatment of this disease.
One of the things that makes our trials unique is that we are testing a vaccination treatment approach for people who have been diabetic for many years. This is unlike other type 1 diabetes trials, which tend to look at ways to prevent or delay type 1 diabetes, or to focus only on those who have just been diagnosed. While necessary, those trials leave out a whole population of people who have been living with type 1 diabetes for a long time...."
To read more, download the entire newsletter here: DrFaustmanUpdate_1111-web.pdf